杰恩股份 reported revenue of ¥0.13B for the period ended 2026-06-30, -46.1% year on year. Net income was ¥0.00B, a 0.7% net margin on a 20.8% gross margin. The largest revenue line is 市场商务及服务支持业务 at 82% of the total. Free cash flow for the period was ¥-0.00B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.13B | -46.1% |
| Gross profit | ¥0.03B | — |
| Operating income | ¥0.01B | — |
| Net income | ¥0.00B | — |
| Gross margin | 20.8% | Net margin 0.7% |
| Revenue Q/Q | +46.6% | — |
| Segment | Revenue | Share |
|---|---|---|
| 市场商务及服务支持业务 | ¥0.10B | 82.2% |
| 室内设计业务 | ¥0.02B | 15.5% |
| 其他(补充) | ¥0.00B | 2.2% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.10B | 79.2% |
| SG&A | ¥0.02B | 16.9% |
| Tax & other | ¥0.01B | 4.8% |
| Item | Amount |
|---|---|
| Total assets | ¥1.14B |
| Total liabilities | ¥0.35B |
| Shareholders' equity | ¥0.79B |
| Equity / assets | 69.7% |
| Operating cash flow | ¥-0.00B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥-0.00B |
| Cash conversion (OCF / net income) | -3696% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
沪宁股份 ・ 大烨智能 ・ 富满微 ・ 国科微 ・ 佩蒂股份 ・ 宇信科技 ・ 建科院 ・ 华大基因 ・ 英科医疗 ・ 中科信息 ・ 电连技术 ・ 隆盛科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies